Ticker

AMSTERDAM--(BUSINESS WIRE)-- #cardiology--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Imricor Medical Systems (ASX: IMR), a pioneer and world-leading developer of MR-compatible products for interventional MR procedures, today announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The first commercially available configuration* combines Philips' 1.5T MRI platform…

August 27, 2026 The solution combines Philips' high-performance 1.5T MRI platform and advanced interventional workflow capabilities with Imrico r' s exclusive portfolio of systems and consumables for MR-guided cardiac interventions. Amsterdam, the Netherlands – August 27, 2026: Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Imricor Medical Systems (ASX: IMR), a pioneer and…

August 26, 2026               Philips receives up to US$33.7 million award from ARPA-H to expand access to AI-enabled robotic stroke care, supporting the program's goal of expanding access to specialized interventions Philips will collaborate with Johns Hopkins University and Boston University to develop technologies for remote and increasingly automated endovascular procedures Building on Philips' leadership in…

August 24, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 650 million fixed rate notes due 2034 (the “Notes”) under its European Medium Term Note (EMTN) program. The Notes are the healthcare industry's first EU Green Bond under the new European Green Bond Standard.

Bank of America Corp DE grew its holdings in shares of Koninklijke Philips N.V. (NYSE: PHG) by 7.7% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 700,141 shares of the technology company's stock after purchasing an additional 50,124